OpenFilings

Allarity Therapeutics, Inc.

Form10-K

Report Period2021-12-31

Date Filed2022-05-17

Time Filed19:12:56

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

ANNUAL REPORT
DESCRIPTION OF CAPITAL STOCK
ASSIGNMENT AND ASSUMPTION AGREEMENT BETWEEN ALLARITY THERAPEUTICS, INC. AND ALLA
EXCLUSIVE LICENSE AGREEMENT WITH ONCOHEROES BIOSCIENCE, INC. DATED JANUARY 2, 20
EXCLUSIVE LICENSE AGREEMENT WITH ONCOHEROES BIOSCIENCE, INC. DATED JANUARY 2, 20
AMENDED AND RESTATED LICENSE AGREEMENT AMONG ALLARITY THERAPEUTICS EUROPE APS, L
SUPPORT AGREEMENT BETWEEN ALLARITY THERAPEUTICS A/S AND LIPLASOME PHARMA APS, DA
SUBSIDIARIES OF THE REGISTRANT
CERTIFICATION
CERTIFICATION
CERTIFICATION
CERTIFICATION
Filing on SEC Edgar